대한부인종양학회

최신 논문

총 게시글 : 136

Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial 2024-06-26 VIEW : 3
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer 2024-06-26 VIEW : 17
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial 2024-06-26 VIEW : 5
Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center 2024-03-29 VIEW : 28
Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients 2024-03-29 VIEW : 12
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ ENGOT-ov38): a phase IIIb trial 2024-03-29 VIEW : 16
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018) 2024-03-29 VIEW : 6
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines 2024-03-29 VIEW : 37
Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines 2024-03-29 VIEW : 36
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer 2024-03-29 VIEW : 21
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer 2024-03-29 VIEW : 9
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, singlearm, phase 2 trial 2024-03-29 VIEW : 5
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial 2024-03-29 VIEW : 7
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study 2024-03-29 VIEW : 9
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients – An international pooled analysis of three ESGO accredited centres 2024-03-29 VIEW : 5

1
2
3
4
5
6
7
8
9
10